The pharmacokinetics and bacteriological efficacies of penicillin G, ceftriaxone, vancomycin, and imipenem were determined in rabbits with experimental meningitis caused by Streptococcus pneumoniae strains with different penicillin susceptibilities. Drug dosages were adjusted to attain peak concentrations in serum that were similar to those observed in infants and children. In animals infected with a penicillin-susceptible (MBC, 0.008 ,ug/ml) pneumococcus, penicillin G and ceftriaxone reduced the number of organisms in cerebrospinal fluid (CSF) by .4.14 logl0 CFU/ml after single doses and after 9-h continuous infusions. A single large dose (50 mg/kg) of penicillin G was comparatively ineffective (-2.15 log10 CFU/ml) against a relatively penicillin-resistant (MBC, 0.5 ,ug/ml) strain, whereas ceftriaxone therapy resulted in a 3.66-and 4.77-loglo CFU/ml reduction after single doses and 9-h continuous infusions, respectively. In animals in which meningitis was caused by a penicillin-resistant (MBC, 8.0 ,ug/ml) (1, 3, 8, 9, 11, (16) (17) (18) . Relatively resistant S. pneumoniae strains have MICs of 0.1 to 1.0 pig of penicillin per ml and a prevalence rate of 3 to 16% (1, 2, 9). We recently reported that, of S. pneumoniae strains obtained from cultures of infants and children at Children's Medical Center, Dallas, Tex., in a 17-month period from 1981 to 1983, 8% were relatively penicillin resistant (9). In this report, two infants with meningitis caused by these strains failed to respond to conventional doses of penicillin (250,000 U/kg per day); one infant was successfully treated with chloramphenicol, but the second required vancomycin for cure because the strain was also resistant to chloramphenicol. Others have also used chloramphenicol alone or with penicillin for therapy of meningitis caused by relatively resistant S. pneumoniae strains (1, 11, 16, 17 
experiments, a bactericidal titer of .1:8 in CSF was necessary to achieve a maximal bacteriological effect.
In recent years, strains of Streptococcus pneumoniae that are relatively resistant and resistant to penicillin have caused meningitis in infants and children (1, 3, 8, 9, 11, (16) (17) (18) . Relatively resistant S. pneumoniae strains have MICs of 0.1 to 1.0 pig of penicillin per ml and a prevalence rate of 3 to 16% (1, 2, 9) . We recently reported that, of S. pneumoniae strains obtained from cultures of infants and children at Children's Medical Center, Dallas, Tex., in a 17-month period from 1981 to 1983, 8% were relatively penicillin resistant (9) . In this report, two infants with meningitis caused by these strains failed to respond to conventional doses of penicillin (250,000 U/kg per day); one infant was successfully treated with chloramphenicol, but the second required vancomycin for cure because the strain was also resistant to chloramphenicol. Others have also used chloramphenicol alone or with penicillin for therapy of meningitis caused by relatively resistant S. pneumoniae strains (1, 11, 16, 17) .
Meningitis caused by penicillin-resistant S. pneumoniae (MIC, >1 jig/ml) was reported in three South African infants in 1977 (3) and in an infant from Denver, Colo., in 1981 (18) . Only the latter infant survived; however, the responses to ampicillin, choramphenicol, and rifampin therapy was delayed. The penicillin-resistant strains have generally shown cross-resistance to most other beta-lactam antibiotics and to chloramphenicol.
In the present investigation, the experimental rabbit meningitis model was used to assess the pharmacokinetics and bacteriological efficacy of ceftriaxone against a relatively penicillin-resistant pneumococcal strain and of ceftriaxone, vancomycin, and imipenem against a penicillin-resistant pneumococcal strain. Ceftriaxone was chosen because of its documented efficacy and safety in the therapy of non-neo-natal meningitis caused by Haemophilus influenzae, Neisseria meningitidis, and penicillin-susceptible strains of S. pneumoniae (5, 7, 23) . Because ceftriaxone might someday replace conventional ampicillin and chloramphenicol therapy for initial, empirical treatment of meningitis, it is important to know whether it is effective against these increasingly prevalent, relatively penicillin-resistant strains of S. pneumoniae. Although penicillin-resistant pneumococcal strains are still rarely encountered in the United States, in vitro susceptibility data (10, 24) and results from one study in experimental animals (4) ml of MgCl2, and 0.5 ml of CaC12 before each experiment. An inoculum of 1 x 105 to 4 x i07 CFU was inoculated intracisternally.
Rabbit model. New Zealand white male rabbits, weighing 2 to 3 kg each, were prepared by the method of Dacey and Sande (6) and Scheld et al. (21) . Antibiotics were administered intravenously at 14 to 18 h after intracisternal inoculation of S. pneumoniae. At this time the animals were lethargic and febrile, and cultures of purulent CSF grew 3.73 to 5.57 log1o CFU/ml. The CSF leukocyte counts were 120 to 3,820/mi3 (mean, 828/m3), and the protein concentrations were 62 to 480 mg/dl (mean, 136 mg/dl). All animals were sacrificed by an overdose of pentobarbital after completion of the experiments.
Administration of drugs. The antibiotics were dissolved in sterile water to the desired concentration. Antibiotic assays. Concentrations of antibiotic were measured by an agar disk diffusion microbioassay method with Sarcina lutea ATCC 9341 for penicillin G and vancomycin, Escherichia coli R01346 for ceftriaxone, and Bacillus subtilis MB3Z and SDR (Glaxo) for imipenem. Serum and CSF from untreated healthy and infected rabbits did not inhibit the assay organisms. Standards and serum samples were diluted in 100% normal rabbit serum, whereas standards and CSF samples were diluted in phosphate buffer (pH 6.0). The intraassay variability was s5% (coefficient of variation) and the interassay variability was l10% for the five antibiotics.
Titers in CSF and serum. Bacteriostatic and bactericidal titers in CSF against each strain causing meningitis were determined by a microtiter technique (12) log1o CFU/ml at 5 h after the dose. At this time, four of five animals had sterile CSF cultures. In contrast, the log1o CFU of S. pneumoniae per milliliter increased by 1.51 in the CSF of seven untreated animals. When these two antibiotics were given by constant infusion over 9 h, the median bactericidal titers in CSF were 1 dilution higher than peak values after a single dose, and the bacteriological results were similar.
(ii) Meningitis caused by a relatively penicillin-resistant S. pneumoniae strain. A larger dose of penicillin G (150 mg/kg) was given as a single dose to animals infected with a relatively penicillin-resistant (MBC, 0.5 p.g/ml) strain of S. pneumoniae (Table 3 ). The peak bactericidal titer in CSF was 1:4, and the numbers of organisms in CSF were reduced by only 2.15 log1o CFU/ml. CSF from one of four animals was sterile at S h. Ceftriaxone (MBC, 0.5 ,ug/ml) produced a similar bactericidal titer in CSF and reduced the number of bacteria in CSF by 3.66 log1o CFU/ml. Two of five animals had sterile cultures at 5 h. In five untreated animals, the colony count in CSF increased by 1.8 log1o CFU/ml. After a 9-h constant infusion, ceftriaxone decreased the numbers of organisms in CSF by 4.77 log1o CFU/ml, and cultures were sterile in all four animals. The median bactericidal titer in CSF was 1:8 against this relatively resistant strain. In five untreated animals, the colony count increased by 1.86 log1o CFU/ml after 9 h, and none of five animals had sterile CSF cultures.
(iii) Meningitis caused by a penicillin-resistant S. pneumoniae strain (MBC, 8.0 ,ug/ml). In single-dose experiments both a conventional and a large dose of penicillin G were ineffective and failed to produce detectable bactericidal activity in CSF (Table 4 ). The numbers of organisms in CSF increased by 1.2 to 1.5 log1o CFU/ml, an effect similar to that observed in five untreated animals. A single dose of ceftriaxone (MBC, 2.0 ,ug/ml) produced a peak bactericidal titer of only 1:2, and the initial numbers of organisms in CSF (5.47 log1o CFU/ml) were unchanged at 5 h. By contrast, van- comycin (MBC, 0.5 pg/ml) and imipenem (MBC, 0.5 pig/ml) reduced the numbers of S. pneumoniae by 2.19 and 2.42 log10 CFU/ml, respectively. Cultures of CSF from one of five animals treated with vancomycin and one of four animals treated with imipenem were sterile at 5 h. Because penicillin G and ceftriaxone were ineffective in the single-dose experiments, only vancomycin and imipenem were evaluated in constant-infusion experiments in animals infected with the penicillin-resistant pneumococcal strain. Median bactericidal titers of 1:8 were achieved in CSF with both drugs. In all animals treated with vancomycin or imipenem, the bacterial counts in CSF were reduced by >4 log10 CFU/ml and all CSF cultures were sterile.
DISCUSSION
The rabbit model of meningitis has been useful to investigators as a means to predict in humans penetration of antimicrobial agents through inflamed meninges and bactericidal titers against common meningeal pathogens that are achieved in CSF with these agents (13) . Although bacteriological results from these in vivo studies do not necessarily correlate with clinical efficacy in humans with meningitis, the model has become an essential early step in the process of evaluating investigational antibiotics or of determining alternative therapeutic regimes for meningitis caused by organisms that have developed resistance to conventionally used drugs. Caution must be used in directly applying data from this model to clinical situations.
In the present study, a relatively penicillin-resistant strain and a penicillin-resistant strain of S. pneumoniae were used to produce meningitis in rabbits, and ceftriaxone and imipenem, two investigational agents, and vancomycin, an agent not yet approved for the therapy of pneumococcal meningitis, were evaluated. Penicillin G and ceftriaxone were comparably effective in rabbits infected with a penicillin-susceptible strain. In contrast, penicillin in large doses (150 mg/kg) was comparatively ineffective against the relatively resistant strain and failed against the resistant pneumococcal strain. A 9-h continuous infusion of ceftriaxone sterilized CSF cultures of four animals with meningitis caused by the relatively resistant strain, whereas a single dose of ceftriaxone failed to reduce the bacterial count in CSF of animals with meningitis caused by the penicillin-resistant strain. Both vancomycin and imipenem produced excellent bacteriological results against the penicillin-resistant pneumococcus.
The concentrations achieved in the sera of these animals approximated the therapeutic concentrations in infants and children and were similar to those previously reported for this model by our laboratory (15, 19) and others (4, 11, 21) . After the large dose of penicillin, the 0.25-h serum specimens contained concentrations that were approximately 10-fold greater than those found in children after conventional doses; the mean concentration at the end of the 150-mg/kg infusion exceeded 800 ,ug/ml. Even so, the bacteriological effect after these large doses was poor in animals infected with a relatively resistant or resistant strain of S. pneumoniae.
The concentrations of penicillin and ceftriaxone found in CSF of infected animals were 2 to 6% of those found in serum; this degree of penetration for both drugs was similar to values reported by others for this model (21, 22) . As shown previously by us (19) , imipenem penetrates well through inflamed meninges. Beam (4) showed the penetration of vancomycin after 8-h infusions to be approximately 15 and 18% in experimental pneumococcal meningitis after doses of 8 and 20 mg/kg, respectively. In our continuous-infusion experiments, the penetration of vancomycin was 10%. After single doses, however, vancomycin was undetected in CSF at 0.25 and 0.5 h after the dose and was detected in only one of four samples at 1 h.
Bactericidal titers in CSF usually correlate well with bacteriological outcome in experimental meningitis and in humans with meningitis. Sande (20) and McCracken (14) have previously shown that a minimum bactericidal titer of 1:8 to 1:10 in CSF is required for an optimal bacteriological and clinical result. Titers exceeding these values have not correlated with a superior effect (7) . In this study, a titer of <1:4 in CSF was associated with smaller reductions in numbers of S. pneumoniae in CSF compared with results obtained with titers of .1:8. With the exception of one of eight animals treated with penicillin for meningitis caused by the susceptible strain, bacteriological cure was consistently achieved after 9-h continuous infusions in all animals with titers of 21:8 in CSF, regardless of the antibiotic or strain of pneumococcus used.
The results of these studies of experimental S. pneumoniae meningitis must be considered incomplete, because not all of the therapeutic regimens were tested in single-dose and continuous-infusion experiments for each pneumococcal strain. For example, in animals with meningitis caused by a relatively penicillin-resistant strain, the bacteriological effect of penicillin was not evaluated after continuous intravenous infusion. We made this decision because penicillin was only modestly effective after a single dose in this model and because clinical experience indicates that penicillin is usually ineffective in patients with meningitis caused by relatively resistant S. pneumoniae (1, 9, 16) . Similarly, we did not assess penicillin or ceftriaxone after continuous intravenous infusion in animals infected with the penicillin-resistant pneumococcus. These two antibiotics were ineffective after single doses in this model, and penicillin is totally ineffective clinically in patients with meningitis caused by these strains (3, 18) . However, it is possible that, had they been evaluated after 9-h continuous infusions, these drugs would have been bacteriologically effective in our meningitis model. Conclusions from our investigation should be considered tentative until additional studies have been conducted. We believe ceftriaxone should be considered for the therapy of meningitis caused by relatively penicillin-resistant S. pneumoniae, but further experience with the animal model under controlled clinical conditions are required before recommendations can be made. Vancomycin or imipenem might prove effective for the therapy of meningitis caused by penicillinresistant strains. Because clinical experience will be difficult to obtain, additional studies in animals are required.
